Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Taylor

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology|February 23, 2016
Autoantibodies against homocysteinylated protein in a mouse model of folate deficiency-induced neural tube defectsKerina J Denny, Christina F Kelly, Vinod Kumar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 14, 2008
Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administrationMichael Morgan, Andrew C Bulmer, Trent M Woodruff, et al.
Journal of Neuroinflammation|September 27, 2013
Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosisJohn D Lee, Nur A Kamaruzaman, Jenny N T Fung, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2005
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel diseaseTrent M Woodruff, Sandra Pollitt, Lavinia M Proctor, et al.
Journal of Hepatology|May 26, 2004
Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in ratsThiruma V Arumugam, Trent M Woodruff, Shelli Z Stocks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's diseaseMaria I Fonseca, Rahasson R Ager, Shu-Hui Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2013
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilizationMike C L Wu, Faith H Brennan, Jason P L Lynch, et al.
The Journal of Biological Chemistry|January 22, 2005
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding siteAdrian Higginbottom, Stuart A Cain, Trent M Woodruff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 2013
C5a receptor signaling prevents folate deficiency-induced neural tube defects in miceKerina J Denny, Liam G Coulthard, Angela Jeanes, et al.
Shock (Augusta, Ga.)|January 16, 2016
EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITYTrent M Woodruff, Mike C-L Wu, Michael Morgan, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Birth Defects Research. Part A, Clinical and Molecular Teratology|February 23, 2016
Autoantibodies against homocysteinylated protein in a mouse model of folate deficiency-induced neural tube defectsKerina J Denny, Christina F Kelly, Vinod Kumar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 14, 2008
Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administrationMichael Morgan, Andrew C Bulmer, Trent M Woodruff, et al.
Journal of Neuroinflammation|September 27, 2013
Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosisJohn D Lee, Nur A Kamaruzaman, Jenny N T Fung, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2005
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel diseaseTrent M Woodruff, Sandra Pollitt, Lavinia M Proctor, et al.
Journal of Hepatology|May 26, 2004
Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in ratsThiruma V Arumugam, Trent M Woodruff, Shelli Z Stocks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's diseaseMaria I Fonseca, Rahasson R Ager, Shu-Hui Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2013
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilizationMike C L Wu, Faith H Brennan, Jason P L Lynch, et al.
The Journal of Biological Chemistry|January 22, 2005
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding siteAdrian Higginbottom, Stuart A Cain, Trent M Woodruff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 2013
C5a receptor signaling prevents folate deficiency-induced neural tube defects in miceKerina J Denny, Liam G Coulthard, Angela Jeanes, et al.
Shock (Augusta, Ga.)|January 16, 2016
EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITYTrent M Woodruff, Mike C-L Wu, Michael Morgan, et al.
Pageof 7